| artemisinin | fermentation | insulin | prebiotics |
| bacteria | filtration | invertase | quinine |
| amino acid | ethics | herbicide | pasteurisation |
| biotechnology | gelling agent | lactic acid | resistance |
| breeding | gene | lactose | salicin |
| cholesterol | genetic engineering | malaria | stem cells |
| chymosin | genetic modification | microorganism | taxol |
| citric acid | genome | obesity | toxin |
| enzyme | genomics | oligosaccharide | vector |
| ester | glutamic acid | Parkinsons disease | yeast |
| bacteria are used in the production of yoghurt from milk by the conversion of lactose to lactic acid | B3 1.1 |
| the commercial production of soy sauce includes fermentation of a mixture of cooked soya beans and roasted wheat using Aspergillus, further fermentation using yeasts and then Lactobacillus, filtration, pasteurisation, sterile bottling | B3 1.2 |
| other functional foods are not necessarily produced by fermentation, including prebiotics such as oligosaccharides found as a food ingredient on the supermarket shelf, and spreads that contain plant stanol esters that lower cholesterol | B3 1.3 |
| prebiotics are functional foods that are marketed as providing health benefits | B3 1.4 |
| microbial products are used in food, including:
vitamin C produced by Acetobacter spp. (bacterium) carrageen, a gelling agent from seaweed enzymes such as invertase produced by Saccharomyces cerevisiae (yeast) used in the manufacture of sweets citric acid produced by Aspergillus niger (fungus) used in fizzy drinks amino acids such as glutamic acid produced by Corynebacterium glutamicum (bacterium) and the flavour enhancer, monosodium glutamate (MSG), a sodium salt of glutamic acid |
B3 1.5 |
| the production of the enzyme chymosin, produced by genetically altered microorganisms, which is used in the manufacture of vegetarian cheese | B3 1.6 |
| the importance of having a well-balanced diet, in terms of a healthy lifestyle | B3 1.7 |
| the possible consequences of being severely overweight or underweight for your height | B3 1.8 |
| the potential of biotechnology and evaluate in relation to world food shortage, eg kwashiorkor. | B3 1.9 |
| Plant modification weed control to reduce loss of food supplies by genetically modifying crops to ensure they are resistant to herbicides |
B3 1.10 |
| the use of Agrobacterium tumefaciens as a vector to transfer genes coding for herbicide resistance to the genome of a plant cell | B3 1.11 |
| breeding insect-resistant plants including the insertion of the toxin gene from Bacillus thuringiensis and inserting it into plants | B3 1.12 |
| the ethics of genetic modification particularly its use in developing countries. | B3 1.13 |
| Reproduction stem cell research and therapies as possible treatments for diseases such as Parkinsons disease |
B3 1.14 |
| allowing people to choose the sex of their baby may skew the sex balance of the population and may lead to other choices being permitted including colour of eyes | B3 1.15 |
| ethical implications of reproductive research. | B3 1.16 |
| Pharmaceuticals the importance and medicinal value of drugs produced by plants, including: aspirin compound called salicin found in the bark and leaves of willow plants used for pain-relief taxol derived from the bark of the Pacific yew tree and used as an anti-cancer agent quinine which comes from the bark of the cinchona tree: until the 1930s it was the only real treatment for malaria artemisinin and its derivatives extracted from the Chinese plant Artemsia annua used for treating malaria and reducing its transmission |
B3 1.17 |
| consider the advantages and disadvantages of drugs derived from plant sources compared to synthetic drugs | B3 1.18 |
| an awareness of the potential for discovering sources of new drugs, including rainforests | B3 1.19 |
| the production of insulin using genetic engineering: an understanding of the role of recombinant DNA technology including restriction enzyme, ligase and sticky ends | B3 1.20 |
| the role of biotechnology in developing new substances, for example, the use of genomics in medical research to develop personalised medicines. | B3 1.21 |